Alterations of Metastasis-Related Genes Identified Using an Oligonucleotide Microarray of Genistein-Treated HCC1395 Breast Cancer Cells

References

• Gray , G E , Pike , M C and Henderson , B E . 1979 . Breast-cancer incidence and mortality rates in different countries in relation to known risk factors and dietary practices . Br J Cancer , 39 : 1 – 7 .
   PubMed Web of Science ®Google Scholar
• Lee , H P , Gourley , L , Duffy , S W , Esteve , J Lee , J . 1991 . Dietary effects on breast-cancer risk in Singapore . Lancet , 337 : 1197 – 1200 .
   PubMed Web of Science ®Google Scholar
• Wu , A H , Yu , M C , Tseng , C C , Twaddle , N C and Doerge , D R . 2004 . Plasma isoflavone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County . Carcinogenesis , 25 : 77 – 81 .
   PubMed Web of Science ®Google Scholar
• Zheng , W , Dai , Q , Custer , L J , Shu , X O Wen , W Q . 1999 . Urinary excretion of isoflavonoids and the risk of breast cancer . Cancer Epidemiol Biomarkers Prev , 8 : 35 – 40 .
   PubMed Web of Science ®Google Scholar
• Hsieh , C Y , Santell , R C , Haslam , S Z and Helferich , W G . 1998 . Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo . Cancer Res , 58 : 3833 – 3838 .
   PubMed Web of Science ®Google Scholar
• Magee , P J and Rowland , I R . 2004 . Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer . Br J Nutr , 91 : 513 – 531 .
   PubMed Web of Science ®Google Scholar
• Chen , W F , Huang , M H , Tzang , C H , Yang , M and Wong , M S . 2003 . Inhibitory actions of genistein in human breast cancer (MCF-7) cells . Biochim Biophys Acta , 1638 : 187 – 196 .
   PubMed Web of Science ®Google Scholar
• Messina , M , McCaskill-Stevens , W and Lampe , J W . 2006 . Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings . J Natl Cancer Inst , 98 : 1275 – 1284 .
   PubMed Web of Science ®Google Scholar
• Shao , Z M , Wu , J , Shen , Z Z and Barsky , S H . 1998 . Genistein exerts multiple suppressive effects on human breast carcinoma cells . Cancer Res , 58 : 4851 – 4857 .
   PubMed Web of Science ®Google Scholar
• Kousidou , O C , Mitropoulou , T N , Roussidis , A E , Kletsas , D Theocharis , A D . 2005 . Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors . Int J Oncol , 26 : 1101 – 1109 .
   PubMed Web of Science ®Google Scholar
• Jemal , A , Murray , T , Samuels , A , Ghafoor , A Ward , E . 2003 . Cancer statistics, 2003 . CA Cancer J Clin , 53 : 5 – 26 .
   PubMed Web of Science ®Google Scholar
• Clark , G M and McGuire , W . 1988 . Steroid receptors and other prognostic factors in primary breast cancer . Semin Oncol , 15 : 20 – 25 .
   PubMed Web of Science ®Google Scholar
• Major , M A . 2003 . Clinical trials update: medical management of advanced breast cancer . Cancer Nurs , 26 : 10S – 15S .
   PubMedGoogle Scholar
• Giordano , S H , Buzdar , A U , Smith , T L , Kau , S W Yang , Y . 2004 . Is breast cancer survival improving? . Cancer , 100 : 44 – 52 .
   PubMed Web of Science ®Google Scholar
• Brown , P O and Botstein , D . 1999 . Exploring the new world of the genome with DNA microarrays . Nat Genet , 21 : 33 – 37 .
   PubMed Web of Science ®Google Scholar
• Gazdar , A F , Kurvari , V , Virmani , A , Gollahon , L Sakaguchi , M . 1998 . Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer . Int J Cancer , 78 : 766 – 774 .
   PubMed Web of Science ®Google Scholar
• Akiyama , T , Ishida , J , Nakagawa , S , Ogawara , H Watanabe , S . 1987 . Genistein, a specific inhibitor of tyrosine-specific protein kinases . J Biol Chem , 262 : 5592 – 5595 .
   PubMed Web of Science ®Google Scholar
• Duffy , M J , Maguire , T M , Hill , A , McDermott , E and O'Higgins , N . 2000 . Metalloproteinases: role in breast carcinogenesis, invasion and metastasis . Breast Cancer Res , 2 : 252 – 257 .
   PubMed Web of Science ®Google Scholar
• Nagase , H and Woessner , J F Jr. 1999 . Matrix metalloproteinases . J Biol Chem , 274 : 21491 – 21494 .
   PubMed Web of Science ®Google Scholar
• Murray , G I . 2001 . Matrix metalloproteinases: a multifunctional group of molecules . J Pathol , 195 : 135 – 137 .
   PubMed Web of Science ®Google Scholar
• Rha , S Y , Yang , W I , Kim , J H , Roh , J K Min , J S . 1998 . Different expression patterns of MMP-2 and MMP-9 in breast cancer . Oncol Rep , 5 : 875 – 879 .
   PubMedGoogle Scholar
• Talvensaari-Mattila , A , Paakko , P , Hoyhtya , M , Blanco-Sequeiros , G and Turpeenniemi-Hujanen , T . 1998 . Matrix metalloproteinase-2 immunoreactive protein: a marker of aggressiveness in breast carcinoma . Cancer , 83 : 1153 – 1162 .
   PubMed Web of Science ®Google Scholar
• Noe , V , Fingleton , B , Jacobs , K , Crawford , C Vermeulen , S . 2001 . Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 . J Cell Sci , 114 : 111 – 118 .
   PubMed Web of Science ®Google Scholar
• Pacheco , M M , Mourao , M , Mantovani , E B , Nishimoto , I N and Brentani , M M . 1998 . Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinicopathological correlations . Clin Exp Metastasis , 16 : 577 – 585 .
   PubMedGoogle Scholar
• Chung , G G , Zerkowski , M P , Ocal , I T , Dolled-Filhart , M Kang , J Y . 2004 . Beta-catenin and p53 analyses of a breast carcinoma tissue microarray . Cancer , 100 : 2084 – 2092 .
   PubMed Web of Science ®Google Scholar
• Wang , F , Reierstad , S and Fishman , D A . 2006 . Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation . Cancer Lett , 236 : 292 – 301 .
   PubMed Web of Science ®Google Scholar
• Luker , K E and Luker , G D . 2006 . Functions of CXCL12 and CXCR4 in breast cancer . Cancer Lett , 238 : 30 – 41 .
   PubMed Web of Science ®Google Scholar
• Kang , H , Watkins , G , Parr , C , Douglas-Jones , A Mansel , R E . 2005 . Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer . Breast Cancer Res , 7 : R402 – R410 .
   Google Scholar
• Fernandis , A Z , Prasad , A , Band , H , Klosel , R and Ganju , R K . 2004 . Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells . Oncogene , 23 : 157 – 167 .
   PubMed Web of Science ®Google Scholar
• Rao , C N , Reddy , P , Liu , Y , O'Toole , E Reeder , D . 1996 . Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2 . Arch Biochem Biophys , 335 : 82 – 92 .
   Google Scholar
• Rao , C N , Mohanam , S , Puppala , A and Rao , J S . 1999 . Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor . Biochem Biophys Res Commun , 255 : 94 – 98 .
   PubMed Web of Science ®Google Scholar
• Kondraganti , S , Gondi , C S , Gujrati , M , McCutcheon , I Dinh , D H . 2006 . Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line . Int J Oncol , 29 : 25 – 32 .
   PubMed Web of Science ®Google Scholar
• Konduri , S D , Tasiou , A , Chandrasekar , N and Rao , J S . 2001 . Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro . Int J Oncol , 18 : 127 – 131 .
   PubMed Web of Science ®Google Scholar
• Yan , C , Wang , H and Boyd , D D . 2002 . ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter . J Biol Chem , 277 : 10804 – 10812 .
   PubMed Web of Science ®Google Scholar
• Stearns , M E , Kim , G , Garcia , F and Wang , M . 2004 . Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 cells . Mol Cancer Res , 2 : 403 – 416 .
   PubMed Web of Science ®Google Scholar
• Bottone , F G Jr , Moon , Y , Kim , J S , Alston-Mills , B Ishibashi , M . 2005 . The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3) . Mol Cancer Ther , 4 : 693 – 703 .
   PubMed Web of Science ®Google Scholar
• Maass , N , Hojo , T , Zhang , M , Sager , R Jonat , W . 2000 . Maspin—a novel protease inhibitor with tumor-suppressing activity in breast cancer . Acta Oncol , 39 : 931 – 934 .
   PubMedGoogle Scholar
• Swiercz , R , Keck , R W , Skrzypczak-Jankun , E , Selman , S H and Jankun , J . 2001 . Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice . Oncol Rep , 8 : 463 – 470 .
   PubMedGoogle Scholar
• Mahoney , M G , Simpson , A , Jost , M , Noe , M Kari , C . 2002 . Metastasis-associated protein (MTA)1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes . Oncogene , 21 : 2161 – 2170 .
   PubMed Web of Science ®Google Scholar
• Rabbani , S A and Mazar , A P . 2001 . The role of the plasminogen activation system in angiogenesis and metastasis . Surg Oncol Clin N Am , 10 : 393 – 415 .
   PubMedGoogle Scholar
• Pakneshan , P , Szyf , M and Rabbani , S A . 2005 . Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells . Carcinogenesis , 26 : 557 – 564 .
   PubMed Web of Science ®Google Scholar
• Uekita , T , Gotoh , I , Kinoshita , T , Itoh , Y Sato , H . 2004 . Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors . Biol Chem , 279 : 12734 – 12743 .
   Google Scholar
• Sarkar , F H and Li , Y . 2002 . Mechanisms of cancer chemoprevention by soy isoflavone genistein . Cancer Metastasis Rev , 21 : 265 – 280 .
   PubMed Web of Science ®Google Scholar
• Dalu , A , Haskell , J F , Coward , L and Lamartiniere , C A . 1998 . Genistein, a component of soy, inhibits the expression of the EGF and ERBB2/NEU receptors in the rat dorsolateral prostate . Prostate , 37 : 36 – 43 .
   PubMed Web of Science ®Google Scholar